Also, in ARQ's view this well is at an "exciting" stage. So the report can be construed many ways. However, the market cannot discount ARQ downplaying their enthusiasm. Their share performance has been woeful and the easiest way to erode faith would to overblow these well results at this stage...
- Forums
- ASX - By Stock
- spoke to company
EMR
emerald resources nl
Add to My Watchlist
0.50%
!
$3.96

Also, in ARQ's view this well is at an "exciting" stage. So the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$3.96 |
Change
-0.020(0.50%) |
Mkt cap ! $2.604B |
Open | High | Low | Value | Volume |
$4.00 | $4.04 | $3.94 | $7.670M | 1.934M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | $3.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$3.97 | 5225 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 254 | 3.930 |
1 | 2525 | 3.920 |
2 | 1950 | 3.910 |
1 | 12668 | 3.900 |
1 | 2570 | 3.890 |
Price($) | Vol. | No. |
---|---|---|
4.200 | 134 | 1 |
4.220 | 2300 | 1 |
4.240 | 780 | 1 |
4.250 | 20110 | 2 |
4.390 | 2083 | 1 |
Last trade - 16.10pm 04/07/2025 (20 minute delay) ? |
Featured News
EMR (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online